Envista (NYSE:NVST) SVP Mischa Reis Sells 8,000 Shares of Stock

Envista Holdings Corporation (NYSE:NVST) SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the transaction, the senior vice president directly owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This represents a 22.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Envista Stock Up 0.5%

NVST opened at $27.34 on Tuesday. The business’s fifty day simple moving average is $26.95 and its 200 day simple moving average is $26.33. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. The stock has a market cap of $4.39 billion, a PE ratio of 47.15, a P/E/G ratio of 1.30 and a beta of 0.86.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $730.50 million during the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on NVST. Barclays decreased their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Mizuho set a $29.00 price target on Envista in a research report on Thursday, August 6th. BMO Capital Markets began coverage on Envista in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target on the stock. JPMorgan Chase & Co. boosted their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Finally, Evercore reissued an “outperform” rating and set a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Envista presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.31.

Institutional Trading of Envista

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. California State Teachers Retirement System lifted its position in shares of Envista by 2,460.3% in the 2nd quarter. California State Teachers Retirement System now owns 4,972,429 shares of the company’s stock worth $131,024,000 after purchasing an additional 4,778,217 shares during the period. Millennium Management LLC raised its stake in Envista by 1,442.7% in the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after buying an additional 2,263,712 shares in the last quarter. Holocene Advisors LP bought a new position in Envista in the second quarter worth about $43,936,000. Arrowstreet Capital Limited Partnership lifted its holdings in Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after buying an additional 2,210,847 shares during the period. Finally, Norges Bank purchased a new stake in Envista in the fourth quarter worth about $45,113,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.